Milestone Scientific (MLSS) Competitors $0.43 -0.01 (-1.94%) Closing price 03:59 PM EasternExtended Trading$0.43 0.00 (-0.44%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLSS vs. AVR, LAKE, HYPR, STSS, LUCD, MBOT, LNSR, RCEL, OBIO, and SPAIShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Anteris Technologies Global (AVR), Lakeland Industries (LAKE), Hyperfine (HYPR), Sharps Technology (STSS), Lucid Diagnostics (LUCD), Microbot Medical (MBOT), LENSAR (LNSR), Avita Medical (RCEL), Orchestra BioMed (OBIO), and Safe Pro Group (SPAI). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Its Competitors Anteris Technologies Global Lakeland Industries Hyperfine Sharps Technology Lucid Diagnostics Microbot Medical LENSAR Avita Medical Orchestra BioMed Safe Pro Group Anteris Technologies Global (NASDAQ:AVR) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment. Does the media prefer AVR or MLSS? In the previous week, Milestone Scientific had 6 more articles in the media than Anteris Technologies Global. MarketBeat recorded 10 mentions for Milestone Scientific and 4 mentions for Anteris Technologies Global. Anteris Technologies Global's average media sentiment score of 0.24 beat Milestone Scientific's score of -0.13 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Milestone Scientific 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer AVR or MLSS? Anteris Technologies Global presently has a consensus price target of $16.50, indicating a potential upside of 178.25%. Milestone Scientific has a consensus price target of $1.25, indicating a potential upside of 187.42%. Given Milestone Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Milestone Scientific is more favorable than Anteris Technologies Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anteris Technologies Global 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is AVR or MLSS more profitable? Anteris Technologies Global has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Anteris Technologies Global's return on equity of 0.00% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Anteris Technologies GlobalN/A N/A N/A Milestone Scientific -52.01%-60.26%-40.23% Do insiders & institutionals believe in AVR or MLSS? 5.8% of Milestone Scientific shares are held by institutional investors. 4.0% of Anteris Technologies Global shares are held by company insiders. Comparatively, 24.8% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has better valuation and earnings, AVR or MLSS? Milestone Scientific has higher revenue and earnings than Anteris Technologies Global. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnteris Technologies Global$2.70M79.20-$76.29MN/AN/AMilestone Scientific$9.08M3.76-$6.93M-$0.09-4.83 SummaryMilestone Scientific beats Anteris Technologies Global on 7 of the 13 factors compared between the two stocks. Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$34.17M$22.78M$6.15B$21.85BDividend YieldN/AN/A5.72%3.63%P/E Ratio-6.2112.4329.4732.72Price / Sales3.761.59587.1165.90Price / CashN/A12.8025.8218.06Price / Book3.951.6112.524.71Net Income-$6.93M-$5.31M$3.32B$1.02B7 Day Performance-19.27%-7.13%2.43%0.91%1 Month Performance-16.16%-6.02%8.78%0.33%1 Year Performance-49.25%-23.94%62.11%10.85% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific2.0617 of 5 stars$0.43-1.9%$1.25+187.4%-48.2%$34.17M$9.08M-6.2130Short Interest ↑Gap UpAVRAnteris Technologies Global1.8301 of 5 stars$4.45flat$16.50+270.8%N/A$160.47M$2.70M0.00138Short Interest ↑LAKELakeland Industries4.322 of 5 stars$16.47+2.0%$25.00+51.8%-23.0%$157.62M$167.21M-6.012,100HYPRHyperfine1.5169 of 5 stars$1.97-2.0%$1.28-34.9%+30.0%$157.55M$12.89M-3.86190STSSSharps Technology1.4533 of 5 stars$5.84+1.8%N/A-99.5%$156.14MN/A0.003Positive NewsShort Interest ↓Gap UpLUCDLucid Diagnostics3.5382 of 5 stars$1.17-1.3%$3.70+217.6%+40.9%$155.50M$4.35M-0.9870MBOTMicrobot Medical2.5078 of 5 stars$2.90-3.8%$12.00+314.5%+181.6%$152.93MN/A-4.9920Short Interest ↓LNSRLENSAR1.4713 of 5 stars$12.03+0.5%$15.00+24.7%+116.6%$143.58M$53.49M-2.86110RCELAvita Medical2.7251 of 5 stars$5.27+0.8%$11.60+120.1%-62.5%$140.55M$64.25M-2.68130Analyst ForecastOBIOOrchestra BioMed3.0356 of 5 stars$3.44+7.8%$13.50+292.4%-37.9%$132.92M$2.64M-1.884News CoverageSPAISafe Pro Group2.331 of 5 stars$7.02-1.5%$10.50+49.5%+277.6%$131.61M$2.17M-8.7511News CoverageNegative NewsShort Interest ↑ Related Companies and Tools Related Companies Anteris Technologies Global Alternatives Lakeland Industries Alternatives Hyperfine Alternatives Sharps Technology Alternatives Lucid Diagnostics Alternatives Microbot Medical Alternatives LENSAR Alternatives Avita Medical Alternatives Orchestra BioMed Alternatives Safe Pro Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MLSS) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
